Introduction: Multiple soft tissue sarcomas (STS) in extremities are rare. They are either multifucal primaries such as Kaposi and lymphangio-sarcomas, or multifocal recurrences after prior surgical intervention(s). Amputation of the limb is usually performed. ILP with TNF+M is an established option in the treatment of locally advanced STS. For patients (pts) with multiple sarcomas it may be the only way to avoid amputation. As a result of international referral patterns we treated a large number of these rare pts in the period 1991-2003 and evaluated the effect ofTNF-based ILE Patients and Methods: Out of 240 consecutive TNF-based ILPs in STS pts there were 65 ILPs in 54 pts for multifocal primary sarcomas (n=17) or (re-)recurrent (n=48) multiple sarcomas (2-> 100). Eighteen arm ILPs and 47 leg ILPs were performed in 30 females and 24 males, median age 65, range 20-88. All pts were amputation candidates. In 26 ILPs radiotherapy, chemotherapy, ILP or a combination of these modalities had preceded the ILl?. ILPs were performed with 1-4 mg TNF in combination with Melphalan (10-13 mg/L for leg and arm respectively), at tissue temperatures of 38-39.5~ Results: Overall response rate was 85% with complete responses in 27 (41.6%), partial responses in 28 (43.1%), stable disease in 8 (12.3%) and progressive disease after 1 ILP (1.5%). Limb salvage was achieved in 44/54 pts (81%). Perfusion reaction was mild to moderate (Wieberdink grade 1-3), with a grade 4 reaction in only 1 patient. No grade 3-4 systemic toxicity occurred. At a median follow-up of 22.4 months (mean 30.1, range 2 -129+), 29 local recurrences (29/65=44%) in 23 pts (42,5%) occurred, treated by either a second ILP or by amputation. In some pts dying of metastatic disease a local recurrence was not limb threatening. Nine pts had metastatic disease at the time of ILP and 15 pts were diagnosed with distant metastases after ILP. Conclusions: Amputation was prevented in 81% of pts with multiple sarcomas in their limbs. ILP with TNF+M results in high response rates and excellent local control and should be considered before planning a limb amputation.
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Introduction:
Recently, we showed that pancreas cancer patients have an increased prevalence ofimmunosuppressive CD4+CD25 + regulatory T cells (T~eg) in tumor draining lymph nodes (TDLN). Likewise, in our murine pancreas cancer model, prevalence of Treg increases with tumor growth. Antibody mediated depletion ofTre ~ resulted in smaller tumors and prolonged host survival. In this study, we combined Trig depletion with vaccination and evaluated the local and systemic tumor-specific immune response. Methods: Four groups of C57BL/6J mice were challenged subcutaneously with 2.5x105 cells of the pancreas adenocarcinoma cell line, Pan02. Groups 1 and 3 underwent Treg depletion with 3 weekly i.p. injections ofanti-CD25 antibody; the control groups 2 and 4 received isotype antibody. Groups 1 and 2 received no vaccine, groups 3 and 4 were vaccinated prior to tumor challenge with three weekly s.c. injections of lxl06 lethally irradiated Pan02 cells mixed with 200pg GM-CSE Starting at week 4, representative mice were sacrificed at weekly intervals. Splenocytes and lymphocytes fromTDLN were analyzed for tumor-specific release of IFNy by ELISPOT. Results: Depletion of Tr~ resulted in smaller tumor size (p=0.04 at 4 weeks). Overall, an average of 28.~ spot forming cells (SFC) per 105 tested cells was found. InTreg depleted mice significantly more tumor-specific cells were found in TDLN than in the spleen at weeks 4 and 5 (mean 33.6 and 6.6 SFC/105, respectively; p-0.008). The number of tumor-specific cells remained constant in TDLN over time (36 vs. 35 5 and 28 vs. 27.5 SFC/10 for Trig depleted and undepleted mice at 4 vs. 6 weeks, respectively). However, the number increased in the spleen (6.3 vs. 31, WO.03, and 24 vs. 64, p=0.04). This increase was even more distinct in vaccinated mice (0 vs. 72.5, p=0.001 and 13.5 vs. 56, p-0.002, at 5 vs. 6 weeks). Conclusions:
T depletion results in an increase oftumor-specific effectors initially in the rumor 
